e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Revealing novel asthma immunopathology endotypes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response
T. Nguyen (Newcastle, Barbados), F. Eyers (Newcastle, Barbados), M. Yang (Newcastle, Barbados), P. Foster (Newcastle, Barbados)
Source:
International Congress 2019 – Revealing novel asthma immunopathology endotypes
Session:
Revealing novel asthma immunopathology endotypes
Session type:
Oral Presentation
Number:
1623
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Nguyen (Newcastle, Barbados), F. Eyers (Newcastle, Barbados), M. Yang (Newcastle, Barbados), P. Foster (Newcastle, Barbados). LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response. 1623
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005
Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Relevance of innate immune responses to chronic airway diseases
Source: Annual Congress 2008 - The battle between environmental “invaders” and airway epithelial defences
Year: 2008
Investigation of the very early immune response in viral induced experimental asthma exacerbation
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Rhinovirus induced innate immune responses in the epithelium of severe COPD
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
Oral presentation: Targeting of microRNAs can restore innate anti-viral response in asthma
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014
LSC - 2019 - The skin microbiome drives immune maturation and exacerbation of both skin and airway inflammation
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019
PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Late Breaking Abstract - Hypoxia dampens the allergen-dependent adaptive immune response and ameliorates allergic asthma in vivo
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021
How innate immunity regulates adaptive immunity
Source: Annual Congress 2006 - Targeting innate immunity in respiratory diseases
Year: 2006
Chemokines, innate and adaptive immunity, and respiratory disease
Source: Eur Respir J 2002; 19: 350-355
Year: 2002
Prenatal priming on neonatal innate and adaptive immune responses by the farming environment
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005
Childhood asthma and humoral immune response
Source: Eur Respir J 2005; 26: Suppl. 49, 377s
Year: 2005
Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
Late Breaking Abstract - IL-33 drives influenza-induced exacerbations of asthma by halting anti-viral and Th1 responses
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
A deficient immune response to viral infections predicts asthma persistence in children
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016
A pathogen-activated innate homing pathway that instructs allergic inflammation
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Master switches of T-cell activation and differentiation
Source: Eur Respir J 2007; 29: 804-812
Year: 2007
The importance of innate and adaptive immunity in the formation of various variants of the course of seasonal allergic rhinitis
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept